loading
Meiragtx Holdings Plc stock is traded at $5.878, with a volume of 41,354. It is up +1.29% in the last 24 hours and down -1.59% over the past month. MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
See More
Previous Close:
$5.82
Open:
$5.86
24h Volume:
41,354
Relative Volume:
0.16
Market Cap:
$454.85M
Revenue:
$14.02M
Net Income/Loss:
$-84.03M
P/E Ratio:
-2.2961
EPS:
-2.56
Net Cash Flow:
$-125.54M
1W Performance:
-11.22%
1M Performance:
-1.59%
6M Performance:
+7.18%
1Y Performance:
+7.57%
1-Day Range:
Value
$5.74
$5.89
1-Week Range:
Value
$5.70
$6.71
52-Week Range:
Value
$3.85
$7.60

Meiragtx Holdings Plc Stock (MGTX) Company Profile

Name
Name
Meiragtx Holdings Plc
Name
Phone
646-860-7985
Name
Address
450 EAST 29TH STREET, NEW YORK, NY
Name
Employee
389
Name
Twitter
@MeiraGTx
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
MGTX's Discussions on Twitter

Compare MGTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
MGTX 5.88 454.85M 14.02M -84.03M -125.54M -2.56
VRTX 448.33 115.74B 10.63B -479.80M -1.35B 13.33
REGN 744.03 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.33 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.50 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.75 24.49B 3.30B -501.07M 1.03B 11.54

Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-31-24 Resumed Chardan Capital Markets Buy
Oct-23-20 Initiated RBC Capital Mkts Outperform
Sep-15-20 Resumed BofA Securities Buy
Sep-03-19 Initiated Piper Jaffray Overweight
Feb-27-19 Reiterated Chardan Capital Markets Buy
Jul-03-18 Initiated Barclays Overweight
Jul-03-18 Initiated BofA/Merrill Buy
View All

Meiragtx Holdings Plc Stock (MGTX) Latest News

pulisher
Nov 20, 2024

Chardan Capital Reiterates Buy Rating for MeiraGTx (NASDAQ:MGTX) - Defense World

Nov 20, 2024
pulisher
Nov 18, 2024

Trend Tracker for (MGTX) - Stock Traders Daily

Nov 18, 2024
pulisher
Nov 15, 2024

Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results - Simply Wall St

Nov 15, 2024
pulisher
Nov 15, 2024

MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

MeiraGTx Holdings Reports Significant Losses Amid Strategic Moves - TipRanks

Nov 15, 2024
pulisher
Nov 14, 2024

MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 14, 2024
pulisher
Nov 13, 2024

MeiraGTx wins 3 Rare Pediatric designations and updates on AAV-AIPL1 - The Pharma Letter

Nov 13, 2024
pulisher
Nov 13, 2024

MeiraGTx Holdings plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

MeiraGTx Holdings PLC Q3 2024 Earnings: Revenue Soars to $10.9M, EPS Misses Estimates at -$0.55 - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

MeiraGTx Scores Triple FDA Designations, Reports Strong Parkinson's Data Despite Q3 Loss | MGTX Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 08, 2024

Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good - Benzinga

Nov 08, 2024
pulisher
Nov 08, 2024

(MGTX) Trading Signals - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 01, 2024

Dynamic range: the key to MeiraGTx’s quest to control genes with pills - BioCentury

Nov 01, 2024
pulisher
Oct 29, 2024

Duchenne Muscular Dystrophy Therapeutics Market Trends, Growth Insights, and Forecasts 2033 - WhaTech

Oct 29, 2024
pulisher
Oct 29, 2024

Gene Therapy Market Detailed Analysis and Forecast to 2031 - InsightAce Analytic

Oct 29, 2024
pulisher
Oct 28, 2024

Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity - BioWorld Online

Oct 28, 2024
pulisher
Oct 22, 2024

MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress - The Manila Times

Oct 22, 2024
pulisher
Oct 21, 2024

High Growth Tech Stocks to Watch in October 2024 - Simply Wall St

Oct 21, 2024
pulisher
Oct 19, 2024

MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains? - MSN

Oct 19, 2024
pulisher
Oct 18, 2024

(MGTX) Long Term Investment Analysis - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 17, 2024

Cell therapy weekly: US$225 million investment towards world-class research institute - RegMedNet

Oct 17, 2024
pulisher
Oct 16, 2024

MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study - Clinical Trials Arena

Oct 16, 2024
pulisher
Oct 16, 2024

MeiraGTx Holdings plc Inc. (MGTX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Oct 16, 2024
pulisher
Oct 16, 2024

MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results - Yahoo Finance

Oct 16, 2024
pulisher
Oct 15, 2024

Items Tagged with 'glutamic acid decarboxylase' - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Items Tagged with 'AAV-GAD' - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Meiragtx looks to a phase III in Parkinson’s - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints - AOL

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx: Positive PD Data Moves Needle Forward For Regulatory Meetings (NASDAQ:MGTX) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx (MGTX) Sees Stock Surge After Clinical Results News - Stocks Telegraph

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx stock gains on Parkinson’s drug data (NASDAQ:MGTX) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 15, 2024

Investors in MeiraGTx Holdings (NASDAQ:MGTX) from three years ago are still down 75%, even after 13% gain this past week - Simply Wall St

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx reports positive Parkinson's gene therapy trial results By Investing.com - Investing.com UK

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson's Disease - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease - StockTitan

Oct 15, 2024
pulisher
Oct 15, 2024

Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data - Yahoo Finance

Oct 15, 2024
pulisher
Oct 12, 2024

Piper Sandler maintains Overweight rating on MeiraGTx shares - Investing.com

Oct 12, 2024
pulisher
Oct 11, 2024

Piper Sandler maintains Overweight rating on MeiraGTx shares By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 09, 2024

MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference - The Manila Times

Oct 09, 2024
pulisher
Oct 07, 2024

MeiraGTx Holdings plc's (NASDAQ:MGTX) Profit Outlook - Yahoo Finance

Oct 07, 2024
pulisher
Oct 03, 2024

DT Midstream (NYSE:DTM) Price Target Increased to $85.00 by Analysts at Barclays - Defense World

Oct 03, 2024
pulisher
Sep 30, 2024

MeiraGTx's SWOT analysis: gene therapy firm's stock faces pivotal year By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 27, 2024

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains? - Yahoo Finance

Sep 27, 2024
pulisher
Sep 25, 2024

Bank of New York Mellon Corp Sells 14,485 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World

Sep 25, 2024
pulisher
Sep 23, 2024

Beck Capital Management LLC Has $2.07 Million Stock Holdings in Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Financial Metrics Check: Macrogenics Inc (MGNX)’s Ratios for Trailing Twelve Months - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Leonardo Increases Stake In GEM Elettronica To 65% With EUR 16 Mln Investment - XM

Sep 23, 2024
pulisher
Sep 23, 2024

MyCelx drops as revenue guidance pushed on order delay - Proactive Investors USA

Sep 23, 2024
pulisher
Sep 22, 2024

Sei Investments Co. Decreases Stock Position in Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Argent Trust Co Purchases New Stake in Globus Medical, Inc. (NYSE:GMED) - Defense World

Sep 21, 2024

Meiragtx Holdings Plc Stock (MGTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):